Impax Laboratories to Present at the Credit Suisse 2012 Healthcare Conference

Mark Donohue, 215-558-4526Sr. Director, Investor Relations and Corporate Communications

today announced that the Company will present at the Credit Suisse 2012 Healthcare Conference on Wednesday, November 14, at 1:00 p.m. Mountain Standard Time. The conference will be held at the Arizona Biltmore Hotel located in Phoenix, AZ.

Individuals may listen to the live or an archived presentation made at the conference, which will be posted in the investor relations section of the Company’s web site at . This presentation will be archived on the Company’s web site for 30 days.

Impax Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, Impax has developed marketing partnerships to fully leverage its technology platform. Impax Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward, Philadelphia and Taiwan facilities. For more information, please visit the Company's Web site at: .

Suggested Articles

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.

The delay will enable Anixa to perform additional genetic engineering intended to boost the efficacy of the treatment in ovarian cancer.

The new parliamentary arithmetic gives Boris Johnson the numbers to pass the withdrawal agreement and take the U.K. out of the EU.